P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates (Q36648400)

15 August 2017

title

P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates (English)

1 reference

15 August 2017

1 reference

3

Doumbo OK

1 reference

15 August 2017

Plowe CV

1

1 reference

15 August 2017

Kublin JG

series ordinal

2

1 reference

15 August 2017

publication date

1 January 1998

1 reference

15 August 2017

published in

Drug Resistance Updates

1 reference

15 August 2017

volume

1

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

389-396

1 reference

Mass treatment with pyrimethamine; a study of resistance and cross resistance resulting from a field trial in the hyperendemic malarious area of Makueni, Kenya. September 1952-September 1953

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Atovaquone and proguanil for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Activity of PS-15 and its metabolite, WR99210, against Plasmodium falciparum in an in vivo-in vitro model

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Pyrimethamine and Proguanil Resistance-Conferring Mutations in Plasmodium falciparum Dihydrofolate Reductase: Polymerase Chain Reaction Methods for Surveillance in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Dihydrofolate reductase and antifolate resistance in malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Characterisation of the dihydrofolate reductase-thymidylate synthetase gene from human malaria parasites highly resistant to pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Plasmodium falciparum: rapid detection of dihydrofolate reductase mutations that confer resistance to cycloguanil and pyrimethamine.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Prevalence of the dihydrofolate reductase Asn-108 mutation as the basis for pyrimethamine-resistant falciparum malaria in the Brazilian Amazon.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Development and comparison of quantitative assays for the dihydropteroate synthetase codon 540 mutation associated with sulfadoxine resistance in Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Pyrimethamine-resistant Plasmodium falciparum parasites among Tanzanian children: a facility-based study using the polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Susceptibility of Plasmodium falciparum to pyrimethamine and sulfadoxine/pyrimethamine in Kisumu, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Synergistic Antimalarial Activity of Pyrimethamine and Sulfadoxine against Plasmodium falciparum In Vitro *

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Malaria--a neglected disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

High prevalence of mutations in the dihydrofolate reductase gene of Plasmodium falciparum in isolates from Tanzania without evidence of an association to clinical sulfadoxine/pyrimethamine resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Molecular epidemiology of malaria in Yaounde, Cameroon II. Baseline frequency of point mutations in the dihydropteroate synthase gene of Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Molecular epidemiology of malaria in Yaounde, Cameroon I. Analysis of point mutations in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Plasmodium falciparum: mutation pattern in the dihydrofolate reductase-thymidylate synthase genes of Vietnamese isolates, a novel mutation, and coexistence of two clones in a Thai patient

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Molecular assays for surveillance of antifolate-resistant malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Mating patterns in malaria parasite populations of Papua New Guinea.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980014-9

7 January 2021

10.1016/S1368-7646(98)80014-9

Identifiers

DOI

1 reference

15 August 2017

1 reference